The combined treatment, administered at home instead of in a hospital, acts by specifically targeting the proteins produced by the mutant BRAF gene that causes uncontrollably large tumor development.
The NHS has announced that children with brain tumours will soon have access to medications they can take at home.
Clinical trials have demonstrated that the novel medication considerably slows the disease’s course, giving kids a longer, higher quality of life.
Children and young adults with low-grade gliomas that have a certain genetic mutation are eligible for treatment.
It implies that they won’t have to deal with the severe negative effects that chemotherapy may cause.
It has been seen that this combination of dabrafenib and trametinib stops the disease from developing for over three times as long as normal treatment.
Dabrafenib and trametinib have been prescribed to her as part of a Great Ormond Street Hospital research.
“I’m able to just take tablets twice a day and go to the hospital every few months, rather than be in hospital to have chemotherapy,” Aaliyah said.
“I’ve been able to start secondary school with my friends and go to pretty much all my lessons. I’ve also been able to be at home, rather than staying in hospital for treatment, and carry on my hobbies such as majorette.”
The treatment for individuals aged one to seven who have low-grade or high-grade gliomas with a BRAF V600E mutation will now be accessible on the NHS in the next months, thanks to approval from the National Institute for Health and Care Excellence (NICE).
Read More: Click Here
